×

Log in with Linkedin

Log in with Facebook

Log in with emailForgot password?

×

Join with LinkedIn

Join with Facebook

KELLY EMERTON, PhD

Science and Business Advisor

Senior Director of Product Development for Cleveland Clinic Innovations


Dr. Emerton currently runs the US Aortic Stent Graft division of CryoLife, Inc (NYSE: CRY) where she oversees the development of endovascular stent graft technologies into the US market. Previous to that, she spent 5 years at Cleveland Clinic hospital where she oversaw all product development for medical device technologies originating in the hospital system. She also sits on CWRU’s Technology Validation Start-up Fund committee, is on the Medical/Scientific Advisory Board for Temple Therapeutics and Red Crow Medical Investments. Under her Cleveland Clinic tenure, she started 2 spin-off companies in the cardiovascular arena, and was the Chief Operating Officer of Enhale Medical, Inc, the 3rd medical device company she got off the ground. She lends her expertise from 12+ years in product development, formerly with Medtronic, where she led the Endovascular Therapies division’s thoracic pipeline portfolio.

Site Disclaimer

By using this website (the “Site”), you are subject to our Terms of Use and our Privacy Policy. Please read these carefully before proceeding.

The Discovery page offers users the opportunity to preview early-stage companies, which may be under consideration for fundraising on the RedCrow INVEST platform. These companies are not currently raising capital on our Site, and we may not have performed any due diligence or verified that the information they’ve posted is accurate.

Companies actively raising money on our Site are listed on the INVEST platform. Securities are offered through JumpStart Securities, LLC, a registered broker/dealer and FINRA/SIPC member.

RedCrow is not an investment adviser. Listings on the RedCrow site do not imply a recommendation or endorsement by RedCrow.